The Effects of ATLAS Therapy on Nitric Oxide Bioavailability in Patients With Intermittent Claudication
Status:
Recruiting
Trial end date:
2023-02-01
Target enrollment:
Participant gender:
Summary
This study will focus on people with claudication from peripheral arterial disease. The
investigators are researching whether a multicomponent therapeutic can increase the
production of Nitric Oxide in the blood and whether that leads to an improvement in pain free
walking distance and overall physical activity.